ncRNA name
ATB
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-200a
Cancer name
Lung Adenocarcinoma
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/Ī²-Catenin Pathway
Tissue resource
human lung adenocarcinoma cell lines A549
human lung adenocarcinoma cell lines H1975
human lung adenocarcinoma cell lines A549/CDDP
Experiment
None
Institute
Cell Bank of Type Culture Collection of Chinese Academy of Sciences
Country
Continent